TZ Ref No.: TZ-26-1912785
OPTIMsAB - Mapping Immune Escape in Lymphoma and Overcoming It with Novel Optimized Multispecific Antibodies
Doc ref no.
1013•••
Sector
Services
Contract Date
06 Nov 2026
Contract Value
EUR ••••••
Contract Intelligence
AI opportunity notes and scope analysis for this contract award
Opportunity Notes
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Official Award Result
Status: Contract Awarded
Award Date: 06 Nov 2026
Awarded Contractor / Winner
KLIN•••
Awarded Contract Value:
EUR 1,499,100.00
Execution Period:
01 Feb 2027 → 31 Jan 2032
(1825 days)
Contract Description
Novel immunotherapies, such as bispecific antibodies (BiAbs), have transformed lymphoma treatment. Although biAbs are currently mostly used in later lines, their efficacy and scalability are expected to establish them as a major component of first-line treatment. However...